A detailed history of Trust Point Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Trust Point Inc. holds 1,166 shares of UTHR stock, worth $446,309. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,166
Previous 909 28.27%
Holding current value
$446,309
Previous $290 Million 44.3%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$311.04 - $363.55 $79,937 - $93,432
257 Added 28.27%
1,166 $418 Million
Q2 2024

Jul 24, 2024

BUY
$228.26 - $319.04 $207,488 - $290,007
909 New
909 $290 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Trust Point Inc. Portfolio

Follow Trust Point Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Point Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trust Point Inc. with notifications on news.